Linking energy metabolism to chromatin in Huntington's disease – HD-EPIeNERGY
Huntington’s disease (HD) is a rare genetic neurodegenerative disease, primarily affecting the striatum. HD neuron dysfunction starts earlier than anticipated, although early steps of the pathogenic process remain unclear. Altered energy metabolism, including reduced glucose consumption, and depleted histone acetylation at striatal identity genes are two early mechanisms observed in the HD striatum, possibly contributing to striatal dysfunction through progressive loss of striatal neuron identity. Energy metabolism and histone acetylation are tightly coordinated mechanisms. Notably, glucose metabolism controls the production of nuclear acetyl-CoA, the only donor for acetyl groups to histone acetylation. Combining epigenomics, transcriptomics, proteomics, metabolomics, stable-isotope labelling in mice and mouse genetic tools, we aim to investigate new hypothesis that impaired energy metabolism in the HD striatum underlies altered epigenetic regulation, thus contributing to pathogenesis.
Project coordination
Karine Merienne (Université Strasbourg)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partnership
B2A Sorbonne Université
NPS Neuroscience Paris Seine
MTS Commissariat à l'énergie atomique et aux énergies alternatives
LNCA Université Strasbourg
IRIG Commissariat à l'énergie atomique et aux énergies alternatives
Help of the ANR 607,793 euros
Beginning and duration of the scientific project:
September 2022
- 42 Months